Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
about
Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertilityOral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniquesOvarian cyst aspiration prior to in vitro fertilization treatment for subfertilityDifferent ovarian stimulation protocols for women with diminished ovarian reserveSimplification of the clinical phase of IVF and ICSI treatment in programmed cycles.Patient scheduling for gonadotrophin-releasing hormone antagonist protocols.Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF/ICSI procedure?Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles.Use of oral contraceptives in infertile patients: A descriptive review.Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee.Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity.Pretreatment with oral contraceptive pills does not influence the pregnancy rate in the long leuprolide acetate protocol.Elevated basal luteinizing hormone does not impair the outcome of human menopausal gonadotropin and medroxyprogesterone acetate treatment cycles
P2860
Q24187338-C2A4F436-EE54-4C09-BAA0-5B8BB99DA0D9Q24240409-E35C86E6-9927-4857-8437-4478728BC09FQ24244397-F2E9818C-9F7E-4E15-BB84-0DAE89ECCF5FQ24634342-A719A873-DFA4-493E-B73A-9623925B18FAQ33913112-5D1681E1-8A56-4671-8ECC-1F0BF8F8B10FQ34591678-A5F2B31F-330D-4690-B4BF-8E385D08AC4DQ35481149-CD8DE31E-F0D4-4596-AABC-07CE958D1910Q36271924-85129B63-73BC-4226-83E6-EAFBDF4B7683Q36668521-B1F48102-6522-4C27-913E-322C2BDFFE72Q38109225-A387F8C1-8153-4C9A-A2CE-F3BA2E371D93Q38765739-6B640634-44B5-4DD8-9F03-F457186886EEQ48604738-2DFEBDCC-2BE9-4E7F-B658-E5C3B1DAF495Q48660111-38082D6C-ACC2-49AE-A40D-A2538F3B758AQ58740607-354EA98D-A1D4-47D1-BEF6-A4A73826BB8A
P2860
Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Effects of pretreatment with a ...... lantation and pregnancy rates.
@en
Effects of pretreatment with a ...... lantation and pregnancy rates.
@nl
type
label
Effects of pretreatment with a ...... lantation and pregnancy rates.
@en
Effects of pretreatment with a ...... lantation and pregnancy rates.
@nl
prefLabel
Effects of pretreatment with a ...... lantation and pregnancy rates.
@en
Effects of pretreatment with a ...... lantation and pregnancy rates.
@nl
P2093
P1476
Effects of pretreatment with a ...... lantation and pregnancy rates.
@en
P2093
P304
P356
10.1016/S0015-0282(98)00333-1
P407
P577
1998-12-01T00:00:00Z